Established
Semaglutide
GLP-1 receptor agonist. Ozempic, Wegovy, Rybelsus
Royndargøgn fyri hvønn lækna, við upplýsingum um steðgjan sum marknaðarføringin oftast letur út.
Established
GLP-1 receptor agonist. Ozempic, Wegovy, Rybelsus
Established
Dual GIP / GLP-1 receptor agonist. Mounjaro, Zepbound
Established
GLP-1 receptor agonist. Victoza, Saxenda
Established
GLP-1 receptor agonist. Trulicity
Promising
GLP-1 receptor agonist, oral. Rybelsus
Popular but weak
Unapproved compounded preparation. Various, unbranded
Intermittent fasting, time-restricted eating and meal timing, judged on the trial data.
Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.
Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.
Sleep, circadian rhythm and the wearables that claim to measure both.
Henda síða varð sjálvvirkandi týdd úr enskt. Tilvísingarnar og tølini eru óbroytt. Les upprunaliga enska útgávuna um nakað lesist undarliga. Les upprunaliga enska útgávuna